Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Venous Thrombosis

Free Subscription Articles published in BMJ Retrieve available abstracts of 12 articles: HTML format

Single Articles

November 2022
1. AGENO W, Bertu L, Bucherini E, Camporese G, et al
   Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.
   BMJ. 2022;379:e072623.
   PubMed     Abstract available
   
   
   October 2022
2. LI X, Burn E, Duarte-Salles T, Yin C, et al
   Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.
   BMJ. 2022;379:e071594.
   PubMed     Abstract available
   
   
   April 2022
3. HO FK, Pell JP
   Thromboembolism and bleeding after covid-19.
   BMJ. 2022;377:o817.
   PubMed    
   
   
   
4. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Jerndal H, et al
   Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study.
   BMJ. 2022;377:e069590.
   PubMed     Abstract available
   
   
   March 2022
5. MARCUCCI M, Etxeandia-Ikobaltzeta I, Yang S, Germini F, et al
   Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.
   BMJ. 2022;376:e066785.
   PubMed     Abstract available
   
   
   August 2021
6. HIPPISLEY-COX J, Patone M, Mei XW, Saatci D, et al
   Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
   BMJ. 2021;374:n1931.
   PubMed     Abstract available
   
   
   June 2021
7. BLANK M, Collas O, Hirji H
   A young man with shortness of breath.
   BMJ. 2021;373:n1313.
   PubMed    
   
   
   
8. KOVACS MJ, Wells PS, Anderson DR, Lazo-Langner A, et al
   Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
   BMJ. 2021;373:n1205.
   PubMed     Abstract available
   
   
   May 2021
9. HORNER D, Goodacre S, Davis S, Burton N, et al
   Which is the best model to assess risk for venous thromboembolism in hospitalised patients?
   BMJ. 2021;373:n1106.
   PubMed    
   
   
   
10. PERERA R, Fletcher J
    Thromboembolism and the Oxford-AstraZeneca vaccine.
    BMJ. 2021;373:n1159.
    PubMed    
    
    
    
11. POTTEGARD A, Lund LC, Karlstad O, Dahl J, et al
    Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.
    BMJ. 2021;373:n1114.
    PubMed     Abstract available
    
    
    January 2021
12. SALMAN D, Vishnubala D, Le Feuvre P, Beaney T, et al
    Returning to physical activity after covid-19.
    BMJ. 2021;372:m4721.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: